AC
ZURA icon

Aristides Capital’s Zura Bio ZURA Stock Holding History

Aristides Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,600
Closed -$74K – 349
2024
Q4 		$74K Buy
+29,600
New +$105K 0.02% 293

Other funds holding ZURA

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Aristides Capital's ZURA Position: Q1 2025 in Review

Aristides Capital sold out of Zura Bio (ZURA) in Q1 2025, closing a stake of 29,600 shares — an estimated $74K sold.

Aristides Capital first reported a position in ZURA in Q4 2024 and held it in 1 quarter. The position peaked at $74K in Q4 2024. 74 funds tracked by Wall St. Rank hold ZURA as of Q1 2025.

  • Aristides Capital reported no remaining Zura Bio position as of Q1 2025 after selling out during the quarter.
  • Aristides Capital sold 29,600 Zura Bio shares in Q1 2025, an estimated $74K.
  • Aristides Capital first reported a position in Zura Bio in Q4 2024 and held it in 1 quarter.
  • Aristides Capital's Zura Bio position peaked at $74K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Zura Bio as of Q1 2025.

Based on Aristides Capital's 13F filing for Q1 2025, filed 14 May 2025.